Key result
Systemic arterial hypertension was associated with lower distortion-product otoacoustic emission amplitudes at 1501, 2002, and 3003 Hz compared to normotensive controls.
Why the study?
Whether systemic arterial hypertension influences the peripheral auditory system was uncertain.
Does systemic arterial hypertension influence the peripheral auditory system as measured by high-frequency audiometry and otoacoustic emissions in adults with normal conventional audiometry?
Cross-Sectional (n=40)
No
Does systemic arterial hypertension influence the peripheral auditory system as measured by high-frequency audiometry and otoacoustic emissions in adults with normal conventional audiometry?
Answers are grounded in this paper and cite their sources.
Adults with systemic arterial hypertension and normal conventional audiometry exhibit reduced distortion-product otoacoustic emissions, suggesting subclinical cochlear dysfunction.
OBJECTIVE: To determine whether there is any influence of systemic arterial hypertension on the peripheral auditory system. METHODS: This was a cross-sectional study that investigated 40 individuals between 30 and 50 years old, who were divided into groups with and without systemic arterial hypertension, using data from high-frequency audiometry, transient-evoked otoacoustic emissions and distortion-product otoacoustic emissions. The results were compared with those from groups of normal-hearing individuals, with and without systemic arterial hypertension, who underwent the pure-tone audiometry test. All individuals also underwent the following procedures: otoscopy, acoustic immittance measures, pure-tone audiometry at frequencies from 250 to 16000 Hz, transient-evoked otoacoustic emissions test and distortion-product otoacoustic emissions test. RESULTS: No statistically significant difference was observed between the groups with and without systemic arterial hypertension in either conventional or high-frequency audiometry. Regarding transient-evoked otoacoustic emissions, there was a trend toward statistical significance whereby the systemic arterial hypertension group showed lower results. Regarding distortion-product otoacoustic emissions, the systemic arterial hypertension group showed significantly lower results at the following frequencies: 1501, 2002, and 3003 Hz. A discriminant analysis indicated that the distortion-product otoacoustic emissions variables best distinguished individuals with and without systemic arterial hypertension. CONCLUSION: Data from this study suggest cochlear dysfunction in individuals with systemic arterial hypertension because their otoacoustic emission results were lower than those in the systemic arterial hypertension group.
No takes yet. Share an insight, caveat, or question.
Soares et al. (2016) conducted a cross-sectional in Systemic arterial hypertension and peripheral auditory function (n=40). Systemic arterial hypertension (SBP >=140 mmHg or DBP >=90 mmHg) vs. Normotensive adults without systemic arterial hypertension was evaluated on Peripheral auditory system function via high-frequency audiometry, transient-evoked otoacoustic emissions (TEOAE), and distortion-product otoacoustic emissions (DPOAE) (p=<0.05). Systemic arterial hypertension was associated with lower distortion-product otoacoustic emission amplitudes at 1501, 2002, and 3003 Hz compared to normotensive controls.
Synapse has enriched 10 related papers. Consider them for comparative context: